)
FibroBiologics (FBLG) investor relations material
FibroBiologics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Secured HREC approvals in Australia for a Phase 1/2 trial of CYWC628 in diabetic foot ulcers, enabling enrollment of 120 patients at up to 10 sites.
Filed IND with FDA for CYPS317 in psoriasis and expanded patent portfolio for orthopedic and musculoskeletal therapies.
Raised $7.2M through direct offerings and repaid all outstanding debt.
Received Nasdaq extension to regain compliance for continued listing.
Financial highlights
Research and development expenses rose to $7.4M for 2025, up from $4.5M in 2024, mainly due to higher CRO, lab, and personnel costs.
General and administrative expenses remained flat at $9.2M year-over-year, with shifts in personnel, professional fees, and reduced offering and insurance expenses.
Net loss increased to $18.6M for 2025 from $11.2M in 2024, driven by higher R&D and G&A expenses.
Cash and cash equivalents were $4.9M at year-end 2025.
Outlook and guidance
Plans to complete manufacturing and site enrollment for CYWC628 in Q1 2026, dose first patient and report interim results in H1 2026, and report final results by year-end 2026.
Expects IND clearance for CYPS317 in psoriasis and to submit IND for CYMS101 in multiple sclerosis in H1 2026.
Plans to amend IND for degenerative disc disease by end of 2026.
Next FibroBiologics earnings date
Next FibroBiologics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage